Skip to main content
. 2016 Oct 21;7(47):77110–77116. doi: 10.18632/oncotarget.12804

Table 2. Results of this meta-analysis.

Association Heterogeneity
Num SMD (95% CI) P value Model I2 (%) P value
overall 9 −1.08 (−0.136,– 0.08) P < 0.001 R 74.3 P < 0.001
Study design
case-control 6 −1.388 (−1.751, −1.026) P < 0.001 R 47.6 P = 0.09
cohort 3 −0.733 (−0.945, −0.520) P < 0.001 R 52.5 P = 0.122
Race
Caucasian 3 −0.918 (−1.443, −0.393) P < 0.001 R 50.5 P = 0.133
Asian 6 −1.115 (−1.526, −0.784) P < 0.001 R 80.6 P < 0.001
Sample collection
Serum 3 −1.113 (−1.472, −0.755) P < 0.001 R 23.5 P = 0.27
Blood 5 −1.241 (−1.795, −0.678) P < 0.001 R 84.7 P < 0.001
Toenail 1 −0.889 (−1.081, −0.697) P < 0.001 R 0 P < 0.001

Num, number; SMD, standardized mean difference; CI, confidence intercal; R, randomeffects model.